Upsher-Smith launches morphine sulfate tablets
Upsher-Smith is introducing Morphine Sulfate tablets.
The product is available in 15 mg and 30 mg dosage strengths. It comes in 100-count bottles.
Morphine sulfate is an opioid agonist indicated for the relief of moderate to severe acute and chronic pain where the use of an opioid analgesic is appropriate.
Morphine sulfate tablet had a market value of approximately $49 million for the 12 months ended June 2019, according to IQVIA.
The product is available in 15 mg and 30 mg dosage strengths. It comes in 100-count bottles.
Morphine sulfate is an opioid agonist indicated for the relief of moderate to severe acute and chronic pain where the use of an opioid analgesic is appropriate.
Morphine sulfate tablet had a market value of approximately $49 million for the 12 months ended June 2019, according to IQVIA.